1Weber W, Young C, Abdel-Dayem M, et al. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med, 1999,40(4):574.
4Naresh CG, John SR, Geoffrey MG, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural ef fusion. Chest, 2002, 122(6): 1918.
3Fry WA;Menck HR;Winchester DP.The national cancer data base report on lu ng cancer[J],1996.
4Mark MJ;Hazelrigg SR;Landreneau RJ.Thoracoscopy for the diagnosi s o f the indeterminate solitary pulmonary nodule,1993.
5Weber W;Young C;Abdel-Dayem M.Assessment of pulmonary lesions w ith 18 F-fluorodeoxyglucose positron imaging using co incidence mode gamma cameras,1999.
6HigashiK;Ueda Y;Seki H.Fluorine-18-FDG PET imaging is negativ e in bronchioloalveolar carcinoma[J],1998.
7HigashiK;Ueda Y;Sakuma T.Comparison of 18 F-F DG and 201 Tl SPECT in evaluation of pulmonary nodules[J],2001(10).
8Keller T;Bitterlich N;Hilfenhaus S.Tumor markers in the diagnosi si o f bronchial carcinoma:new options using fuzzy logic-based tumor marker profiles[J],1998(10).
9Bousson V;Moretti JL;Weinmann P.Assessment of malignancy in pul mona ry lesions:FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement,2000.
